Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Enterprise Value (2017 - 2025)

Catheter Precision (VTAK) has disclosed Enterprise Value for 9 consecutive years, with -$503000.0 as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 82.49% to -$503000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$503000.0 through Dec 2025, up 82.49% year-over-year, with the annual reading at -$503000.0 for FY2025, 82.49% up from the prior year.
  • Enterprise Value for Q4 2025 was -$503000.0 at Catheter Precision, up from -$1.4 million in the prior quarter.
  • The five-year high for Enterprise Value was -$16000.0 in Q2 2024, with the low at -$20.6 million in Q3 2021.
  • Average Enterprise Value over 5 years is -$8.3 million, with a median of -$5.6 million recorded in 2023.
  • The sharpest move saw Enterprise Value skyrocketed 99.78% in 2024, then tumbled 6637.5% in 2025.
  • Over 5 years, Enterprise Value stood at -$15.0 million in 2021, then fell by 5.41% to -$15.9 million in 2022, then surged by 77.52% to -$3.6 million in 2023, then grew by 19.41% to -$2.9 million in 2024, then surged by 82.49% to -$503000.0 in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$503000.0, -$1.4 million, and -$1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.